Marc Kaufman Related Content

Researchers at McLean Hospital, in collaboration with Nobilis Therapeutics, have been awarded a grant to test a novel xenon gas-based treatment for opioid use disorder. Highlights McLean Hospital researchers have been awarded a grant by the National Institute on Drug Abuse to test xenon gas to...

With new discoveries by McLean Hospital researchers, a fast and effective treatment for PTSD, anxiety, and addiction disorders could be close at hand. Literally. Right now, work is underway to develop a handheld inhaler containing xenon gas that could be used to block traumatic memories as soon as...

Researchers from McLean Hospital have been issued a patent allowance for their invention involving the use of xenon gas to aid in the treatment of addiction and anxiety disorders such as post-traumatic stress disorder (PTSD). The allowance indicates that, pending administrative actions, a patent...

Innovations in neuroimaging enable McLean scientists to investigate the structure and function of the brain to diagnose and develop treatments for many mental health conditions. Now two groundbreaking techniques go a step further: offering the possibility of direct relief from memories of traumatic...

In a study published earlier this year, McLean Hospital researchers found that xenon gas, used in humans for anesthesia and diagnostic imaging, has the potential to be a treatment for post-traumatic stress disorder (PTSD) and other memory-related disorders. “In our study, we found that xenon gas has...

The distance between McLean Hospital and MIT is a mere eight miles, but that is vast in the world of scientific collaborations. Longtime McLean and MIT donors Pat and Jim Poitras decided to bridge the distance by supporting an innovative study bringing together the two research powerhouses to...